Both in Pharmaceuticals
SIGA Technologies vs Akebia Therapeutics
Over the past year SIGA returned −61.6% and AKBA returned −67.3%; their daily moves had a correlation of 0.09.
SIGA −61.6% AKBA −67.3%Growth of $1, one year, split-adjusted
| Metric | SIGA | AKBA |
|---|---|---|
| Price | $3.44 | $0.8861 |
| Market cap | $247.2M | $245.5M |
| Today | −0.58% | −0.78% |
| 1 month | +12.4% | +0.9% |
| 6 months | −34.6% | −32.9% |
| Year to date | −43.7% | −45.0% |
| 1 year | −62.4% | −67.7% |
| Revenue growth (YoY) | −49.5% | −21.4% |
| Gross margin | 57.2% | 78.8% |
| Net margin | 30.4% | −18.1% |
| P/E (TTM) | — | — |
| Price / sales | 4.6× | 1.1× |
| Net cash | $117.6M | $106.0M |
| Dividend yield | 17.44% | — |
| Volatility (60d) | 48.0% | 81.8% |
| Short % of float | 9.2% | 7.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).